UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055979
Receipt number R000063943
Scientific Title Verification of the effect of the gluteus maximus muscle training with electrical stimulation on the pelvic floor muscles.
Date of disclosure of the study information 2024/10/30
Last modified on 2025/11/04 10:06:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the effect of the gluteus maximus muscle training with electrical stimulation on the pelvic floor muscles.

Acronym

Verification of the effect of the gluteus maximus muscle training with electrical stimulation on the pelvic floor muscles.

Scientific Title

Verification of the effect of the gluteus maximus muscle training with electrical stimulation on the pelvic floor muscles.

Scientific Title:Acronym

Verification of the effect of the gluteus maximus muscle training with electrical stimulation on the pelvic floor muscles.

Region

Japan


Condition

Condition

Healthy women in their 30s to 50s who have delivered before

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test, as a pilot study, whether electrical stimulation of the gluteus maximus muscle using Hip Fit strengthens the pelvic floor muscle group.

Basic objectives2

Others

Basic objectives -Others

Verification of Action

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pelvic floor muscle measurements (pelvic floor muscle contraction force and pelvic floor muscle contraction time)
The evaluation periods will be pre-intervention, 6 weeks post-intervention, and 12 weeks post-intervention.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

The study subjects will wear the SIXPAD Hip Fit.
The intervention period will be 12 weeks and will be worn daily for 23 minutes.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

Healthy women in their 30s to 50s who have delivered before

Key exclusion criteria

Those who have received treatment for pelvic organs or urinary incontinence at a medical institution.
Persons with electromagnetic hypersensitivity (physical symptoms such as headache, dizziness, nausea, etc., caused by the use of electrical appliances such as cell phones, computers, wireless LAN, induction cookers, microwave ovens, etc.)
Pacemaker users
Those who have a history of pelvic organ prolapse or pelvic organ abdominal surgery (excluding cesarean section)
Pregnant women and women within 1 year postpartum
Patients with urinary incontinence due to neurological disorders
Patients with a history of cerebrovascular disease or neurological disease.
Those who are out of the standard size range of Hip Fit.
Those who are undergoing pelvic floor muscle training.
Those who have difficulty communicating in Japanese or answering questionnaires.
Those who have difficulty in coming to the hospital for pelvic floor muscle measurement on the designated date.
Those who have contraindications to the use of Hip Fit and those who need to consult a physician.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Hisayo
Middle name
Last name Okayama

Organization

University of Tsukuba

Division name

Institute of Medicine

Zip code

305-8577

Address

1-1-1 Tennodai, Tsukuba City, Ibaraki, Japan

TEL

029-853-8372

Email

okayama@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name Hisayo
Middle name
Last name Okayama

Organization

University of Tsukuba

Division name

Institute of Medicine

Zip code

305-8577

Address

1-1-1 Tennodai, Tsukuba City, Ibaraki, Japan

TEL

029-853-8372

Homepage URL


Email

okayama@md.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

MTG Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Osaka Medical and Pharmaceutical University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Tsukuba

Address

1-1-1 Tennodai, Tsukuba City, Ibaraki, Japan

Tel

029-853-8372

Email

sien.ningenss@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 06 Month 03 Day

Date of IRB

2024 Year 10 Month 16 Day

Anticipated trial start date

2024 Year 10 Month 17 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry

2025 Year 10 Month 31 Day

Date trial data considered complete

2025 Year 10 Month 31 Day

Date analysis concluded

2025 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2024 Year 10 Month 29 Day

Last modified on

2025 Year 11 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063943